(Hypertension. 1996;28:403-408.)
© 1996 American Heart Association, Inc.
Articles |
Tissue-Specific Regulation of Type 1 Angiotensin II Receptor mRNA Levels in the Rat
the Division of Endocrinology, San Francisco General Hospital, University of California, San Francisco (L.A.S., C.A.G., G.G., J.-P.V., M.S.); Hypertension Unit, University of Udine (Italy) School of Medicine (L.A.S.); Clinica di Endocrinologia, University of Ancona (Italy) (G.G.); and INSERM U36, College de France, Paris (C.L.-C., P.C.).
Most of the biological effects of the renin-angiotensin system are mediated by the binding of angiotensin II (Ang II) to the type 1 Ang II (AT1) receptor, the predominant receptor subtype present after fetal life. To study tissue-specific regulation of the expression of the AT1 receptor in the rat, we altered activity of the renin-angiotensin system by feeding rats a low (0.07% NaCl), normal (0.3% NaCl), or high (7.5% NaCl) salt chow for 14 days; infusing Ang II (200 ng/kg per minute IP) or vehicle for 7 days; and administering an angiotensin-converting enzyme inhibitor (captopril, 100 mg/dL in the drinking water) or vehicle for 7 days. Renin, angiotensinogen, and total AT1 receptor mRNA levels were measured by slot-blot hybridization with cRNA probes, and AT1 receptor subtypes (A and B) were measured by reverse transcription–polymerase chain reaction in the presence of a cRNA internal standard. Plasma renin concentration and renal renin, renal and hepatic angiotensinogen, and hepatic AT1 receptor mRNA levels were all inversely related to salt intake; in contrast, renal AT1 receptor mRNA levels were significantly lower in rats fed low salt, a difference that was exclusively due to a decrease in the AT1A subtype. This difference did not appear to be mediated by a change in the circulating levels of Ang II, because Ang II infusion reduced plasma renin concentration and renal renin mRNA with no effect on either angiotensinogen or AT1 receptor mRNA levels in kidney or liver; renal Ang II receptor density (determined by in situ autoradiography) decreased, presumably via a posttranscriptional mechanism. Similarly, inhibition of Ang II generation with captopril increased plasma renin concentration and renal renin mRNA levels without altering renal or hepatic angiotensinogen mRNA or renal AT1 receptor mRNA levels. Thus, AT1 receptor gene expression is regulated in a tissue-specific manner that is distinct from other components of systemic and local renin-angiotensin systems and that appears to be mediated by a mechanism other than through changes in the circulating levels of Ang II.
Key Words: angiotensin II • receptors, angiotensin II • renin • angiotensinogen • captopril
This article has been cited by other articles:
 |
|
 |
|
  Y. Ochiai, Y.-Q. Liang, M. Serizawa, and N. Kato Dynamic changes of the renin-angiotensin and associated systems in the rat after pharmacological and dietary interventions in vivo Physiol Genomics, November 12, 2008; 35(3): 330 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Lu, C. M. Boustany-Kari, A. Daugherty, and L. A. Cassis Angiotensin II increases adipose angiotensinogen expression Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1280 - E1287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sakai, K. Tamura, Y. Tsurumi, Y. Tanaka, Y. Koide, M. Matsuda, T. Ishigami, M. Yabana, Y. Tokita, Y. Hiroi, et al. Expression of MAK-V/Hunk in renal distal tubules and its possible involvement in proliferative suppression Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1526 - F1536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. Cheung, M.-A. H. Kent, E. El-Shahat, H. Wang, J. Tan, R. White, and F. H. H. Leenen Central and peripheral renin-angiotensin systems in ouabain-induced hypertension Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H624 - H630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yoneda, H. Sanada, J. Yatabe, S. Midorikawa, S. Hashimoto, M. Sasaki, T. Katoh, T. Watanabe, P. M. Andrews, P. A. Jose, et al. Differential Effects of Angiotensin II Type-1 Receptor Antisense Oligonucleotides on Renal Function in Spontaneously Hypertensive Rats Hypertension, July 1, 2005; 46(1): 58 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Wu, W. Zheng, and K. Sandberg Estrogen Regulates Adrenal Angiotensin Type 1 Receptors by Modulating Adrenal Angiotensin Levels Endocrinology, April 1, 2003; 144(4): 1350 - 1356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kobori, A. Nishiyama, Y. Abe, and L. G. Navar Enhancement of Intrarenal Angiotensinogen in Dahl Salt-Sensitive Rats on High Salt Diet Hypertension, March 1, 2003; 41(3): 592 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Fletcher, N. Orolinova, and M. Bader Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system J Appl Physiol, February 1, 2002; 92(2): 627 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Nickenig and D. G. Harrison The AT1-Type Angiotensin Receptor in Oxidative Stress and Atherogenesis: Part II: AT1 Receptor Regulation Circulation, January 29, 2002; 105(4): 530 - 536. [Full Text] [PDF]
|
|
|
|
|
|
H. Kobori, L. M. Harrison-Bernard, and L. G. Navar Enhancement of Angiotensinogen Expression in Angiotensin II-Dependent Hypertension Hypertension, May 1, 2001; 37(5): 1329 - 1335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. KOBORI, L. M. HARRISON-BERNARD, and L. G. NAVAR Expression of Angiotensinogen mRNA and Protein in Angiotensin II-Dependent Hypertension J. Am. Soc. Nephrol., March 1, 2001; 12(3): 431 - 439. [Abstract] [Full Text]
|
|
|
|
|
|
A. J. Allred, M. C. Chappell, C. M. Ferrario, and D. I. Diz Differential actions of renal ischemic injury on the intrarenal angiotensin system Am J Physiol Renal Physiol, October 1, 2000; 279(4): F636 - F645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger International Union of Pharmacology. XXIII. The Angiotensin II Receptors Pharmacol. Rev., September 1, 2000; 52(3): 415 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Strehlow, G. Nickenig, J. Roeling, S. Wassmann, O. Zolk, A. Knorr, and M. Bohm AT1 receptor regulation in salt-sensitive hypertension Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1701 - H1707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. MERVAALA, B. DEHMEL, V. GROSS, A. LIPPOLDT, J. BOHLENDER, A. F. MILIA, D. GANTEN, and F. C. LUFT Angiotensin-Converting Enzyme Inhibition and AT1 Receptor Blockade Modify the Pressure-Natriuresis Relationship by Additive Mechanisms in Rats with Human Renin and Angiotensinogen Genes J. Am. Soc. Nephrol., August 1, 1999; 10(8): 1669 - 1680. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Hubert, J.-M. Gasc, S. Berger, G. Schütz, and P. Corvol Effects of Mineralocorticoid Receptor Gene Disruption on the Components of the Renin-Angiotensin System in 8-Day-Old Mice Mol. Endocrinol., February 1, 1999; 13(2): 297 - 306. [Abstract] [Full Text]
|
|
|
|
|
|
L. M. Harrison-Bernard, S. S. El-Dahr, D. F. O'Leary, and L. G. Navar Regulation of Angiotensin II Type 1 Receptor mRNA and Protein in Angiotensin II–Induced Hypertension Hypertension, January 1, 1999; 33(1): 340 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. R. M. Osterop, M. J. M. Kofflard, L. A. Sandkuijl, F. J. t. Cate, R. Krams, M. A. D. H. Schalekamp, and A. H. J. Danser AT1 Receptor A/C1166 Polymorphism Contributes to Cardiac Hypertrophy in Subjects With Hypertrophic Cardiomyopathy Hypertension, November 1, 1998; 32(5): 825 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Tamura, S. Umemura, Y. Sumida, N. Nyui, S.-i. Kobayashi, T. Ishigami, M. Kihara, T. Sugaya, A. Fukamizu, H. Miyazaki, et al. Effect of Genetic Deficiency of Angiotensinogen on the Renin-Angiotensin System Hypertension, August 1, 1998; 32(2): 223 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Gullestad, G. Haywood, H. Aass, H. Ross, G. Yee, T. Ueland, O. Geiran, J. Kjekshus, S. Simonsen, N. Bishopric, et al. Angiotensin II receptor subtype AT1 and AT2 expression after heart transplantation Cardiovasc Res, May 1, 1998; 38(2): 340 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Sumida, S. Umemura, K. Tamura, M. Kihara, S.-i. Kobayashi, T. Ishigami, M. Yabana, N. Nyui, H. Ochiai, A. Fukamizu, et al. Increased Cardiac Angiotensin II Receptors in Angiotensinogen-Deficient Mice Hypertension, January 1, 1998; 31(1): 45 - 49. [Abstract] [Full Text]
|
|
|
|
|
|
L. M. Harrison-Bernard, J. Zhuo, H. Kobori, M. Ohishi, and L. G. Navar Intrarenal AT1 receptor and ACE binding in ANG II-induced hypertensive rats Am J Physiol Renal Physiol, January 1, 2002; 282(1): F19 - F25. [Abstract] [Full Text] [PDF]
|
|